Reuters: Regulatory News: UPDATE 1-Medifast unit settles false ad claims for $3.7 mln

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

UPDATE 1-Medifast unit settles false ad claims for $3.7 mln Sep 7th 2012, 15:56 Fri Sep 7, 2012 11:56am EDT WASHINGTON, Sept 7 (Reuters) - A subsidiary of Medifast Inc agreed to pay a $3.7 million civil penalty and meet new compliance requirements to settle a federal complaint that its claims about weight-loss products were false. Jason Pharmaceuticals Inc, a wholly owned Medifast subsidiary, did not admit liability, according to a consent decree filed on Friday in U.S. District Court for the District of Columbia. The company, the U.S. Justice Department and the Federal Trade Commission are parties to the consent decree. Advertisements for the "Medifast 5 & 1 Plan" low-calorie diet told consumers they could "lose up to 2-5 pounds per week." It did not have a reasonable basis in scientific evidence to support the claims, the government agencies said. Jason Pharmaceuticals said in July that it expected to reach a consent agreement with the Federal Trade Commission over an investigation into its advertising. Medifast did not immediately respond to a request for comment on Friday.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions